Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-22-005216
Filing Date
2022-12-19
Accepted
2022-12-19 08:30:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 p22-2680sc13g.htm SC 13G 77451
  Complete submission text file 0000902664-22-005216.txt   78969
Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 729-3339
Ambrx Biopharma Inc. (Subject) CIK: 0001836056 (see all company filings)

EIN.: 571147346 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92634 | Film No.: 221469676
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address WHITLEY CHAMBERS DON STREET ST. HELIER Y9 JE2 4TR
Business Address WHITLEY CHAMBERS DON STREET ST. HELIER Y9 JE2 4TR (212) 729-7524
Darwin Global Management, Ltd. (Filed by) CIK: 0001839209 (see all company filings)

EIN.: 000000000 | State of Incorp.: Y9 | Fiscal Year End: 1231
Type: SC 13G